Clinical bioequivalence study: Cmax vs. early exposure on the model of two acyclovir immediate-release formulations

被引：0
|
作者：
Zoulova, J. [1 ,2 ]
Kopecky, J. [1 ,2 ]
Chladek, J. [1 ,2 ]
Anzenbacherova, E. [1 ,2 ]
Kubant, P. [1 ,2 ]
Kvitina, J. [1 ,2 ]
Perlik, F. [3 ]
机构：
[1] Joint Res Ctr PRO MED CS Praha As, Inst Expt Biopharmaceut, Hradec Kralove, Czech Republic
[2] Acad Sci Czech Republic, Hradec Kralove, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2004年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：101 / 101
页数：1
相关论文
共 15 条
  • [1] Clinical bioequivalence study of two propafenone formulations: comparison of three measures of absorption rate (Cmax, Cmax/AUC and AUC-early)
    Kopecky, J.
    Zoulova, J.
    Chladek, J.
    Anzenbacherova, E.
    Kvitina, J.
    Perlik, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 100 - 100
  • [2] Pharmacokinetic simulations of topiramate plasma concentrations following dosing irregularities with extended-release vs. immediate-release formulations
    Brittain, Scott T.
    Wheless, James W.
    EPILEPSY & BEHAVIOR, 2015, 52 : 31 - 36
  • [3] Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations
    James, Laura P.
    Chiew, Angela
    Abdel-Rahman, Susan M.
    Letzig, Lynda
    Graudins, Andis
    Day, Peter
    Roberts, Dean
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 851 - 857
  • [4] Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations
    Laura P. James
    Angela Chiew
    Susan M. Abdel-Rahman
    Lynda Letzig
    Andis Graudins
    Peter Day
    Dean Roberts
    European Journal of Clinical Pharmacology, 2013, 69 : 851 - 857
  • [5] Pharmacokinetics comparison between two formulations of lamotrigine: Once-daily extended-release vs twice daily immediate-release tablets
    Ali, Imran
    Oliver-Willwong, R.
    Tompson, D.
    Hammer, A.
    Vuong, A.
    Messenheimer, J.
    EPILEPSIA, 2007, 48 : 369 - 370
  • [6] Comparative Effectiveness and Prescribing Trends of Modified-Release vs. Immediate-Release Indapamide in Patients with Hypertension: A Cohort Study in the UK
    Yan, Vincent Kc
    Ju, Chengsheng
    MacDonald, Thomas M.
    Williams, Bryan
    Mackenzie, Isla S.
    Flynn, Robert Wv
    Yang, Chen
    Chan, Esther W.
    George, Jacob
    Wei, Li
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 217 - 218
  • [7] A Naturalistic Study of De Novo Extended-Release Tacrolimus Tablets vs. Tacrolimus Immediate-Release Capsules in Kidney Transplant Recipients.
    Horwedel, T. A.
    Carthon, C. E.
    January, S. E.
    Gharabagi, A.
    Delos Santos, R.
    Hagopian, J. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 694 - 694
  • [8] Retrospective Claims-Based Comparative Health Outcomes Study: Trokendi XR® (extended-release topiramate) vs. Immediate-Release Topiramate
    O'Neal, W.
    Hur, E. E.
    Liranso, T.
    Turner, R. M.
    HEADACHE, 2016, 56 : 43 - 43
  • [9] 33-week non-inferiority of extended- vs. immediate-release pramipexole tablets in treatment of early Parkinson's disease
    Poewe, W.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Rascol, O.
    Schapira, A.
    Haaksma, M.
    Salin, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 28 - 28
  • [10] Retrospective Claims-Based Comparative Health Outcomes Study: Trokendi XR® (extended-release topiramate) vs. Immediate-Release Topiramate as Migraine Preventives
    O'Neal, Welton
    Hur, Elizabeth E.
    Liranso, Tesfaye
    Chung, Haechung
    Gu, Tao
    Tunceli, Ozgur
    Turner, Ralph M.
    CEPHALALGIA, 2017, 37 : 88 - 89
12